BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22471485)

  • 41. Classification systems for acute and chronic leukaemias.
    Szczepański T; van der Velden VH; van Dongen JJ
    Best Pract Res Clin Haematol; 2003 Dec; 16(4):561-82. PubMed ID: 14592643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunophenotypic, cytogenetic, and clinical features of 207 cases of childhood acute lymphoblastic leukemia in china.
    Tong H; Wang Q; Lu C; Liu Z; Hu Y
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):437-41. PubMed ID: 21792039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Acute leukemia in childhood. Classification--diagnosis--therapy--prognosis].
    Creutzig U; Schrappe M
    Internist (Berl); 1996 Oct; 37(10):982-93. PubMed ID: 9019456
    [No Abstract]   [Full Text] [Related]  

  • 44. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
    Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
    Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunophenotypic and cytogenetic changes in acute leukaemia at relapse.
    Hur M; Chang YH; Lee DS; Park MH; Cho HI
    Clin Lab Haematol; 2001 Jun; 23(3):173-9. PubMed ID: 11553058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunophenotyping by Multiparameter Flow Cytometry.
    Chen W; Luu HS
    Methods Mol Biol; 2017; 1633():51-73. PubMed ID: 28735480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of electron microscopy to the classification of minimally differentiated acute leukemias in children.
    van Wering ER; Brederoo P; van Staalduinen GJ; van der Meulen J; van der Linden-Schrever BE; van Dongen JJ
    Recent Results Cancer Res; 1993; 131():77-87. PubMed ID: 8210661
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells.
    Verheyden S; Ferrone S; Mulder A; Claas FH; Schots R; De Moerloose B; Benoit Y; Demanet C
    Cancer Immunol Immunother; 2009 Jun; 58(6):855-65. PubMed ID: 18841361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunophenotyping of acute lymphatic leukemia: diagnostic aspects and clinical relevance].
    Ludwig WD; Reiter A; Schott G; Schwartz S; Thiel E
    Wien Klin Wochenschr; 1994; 106(8):231-2, 233-7. PubMed ID: 8023515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in India.
    Gujral S; Badrinath Y; Kumar A; Subramanian PG; Raje G; Jain H; Pais A; Amre Kadam PS; Banavali SD; Arora B; Kumar P; Hari Menon VG; Kurkure PA; Parikh PM; Mahadik S; Chogule AB; Shinde SC; Nair CN
    Cytometry B Clin Cytom; 2009 May; 76(3):199-205. PubMed ID: 18803279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The significance of detecting WT1 expression in childhood acute leukemias.
    Hu SY; Gu WY; Chen ZX; Wang XL; Cen JN; He HL; Chai YH; Chen CS
    Pediatr Hematol Oncol; 2010 Nov; 27(8):581-91. PubMed ID: 20863155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency and Aberrant CD Marker Profile of Acute Leukaemias.
    Arshad MZ; Hassan MA; Bibi M; Hussain M; Alam M; Riaz MO
    J Coll Physicians Surg Pak; 2024 May; 34(5):539-544. PubMed ID: 38720213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunophenotyping of acute lymphoblastic leukemia in pediatric patients by three-color flow cytometric analysis.
    Tiensiwakul P; Lertlum T; Nuchprayoon I; Seksarn P
    Asian Pac J Allergy Immunol; 1999 Mar; 17(1):17-21. PubMed ID: 10403005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia].
    Gu LJ; Tie LJ; Jiang LM; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP; Ye H
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):241-5. PubMed ID: 19374802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The diagnostic and prognostic value of immunophenotyping in acute leukemia.
    Bradstock KF
    Pathology; 1993 Oct; 25(4):367-74. PubMed ID: 8165001
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flow cytometric monitoring of residual disease in acute leukemia.
    Wood BL
    Methods Mol Biol; 2013; 999():123-36. PubMed ID: 23666694
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison between CD19 and CD20 expression patterns on acute leukemic cells.
    Ning BT; Tang YM; Chen YH; Shen HQ; Qian BQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):943-7. PubMed ID: 16403255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal antibodies in the management of acute leukemia.
    Wang JC; Beauregard P; Soamboonsrup P; Neame PB
    Am J Hematol; 1995 Nov; 50(3):188-99. PubMed ID: 7485080
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of cost effective diagnostic tools in characterisation of Acute Leukemia in Southern India.
    Sanddhya NS; Kathick D; Sachdanandam P; Thilagavathy S; Shanthi P
    Technol Health Care; 2016 Sep; 24(5):639-46. PubMed ID: 27080214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunological Subtypes of Acute Lymphoblastic Leukemia- Beyond Morphology: Experience from Kidwai State Cancer Institute, Bengaluru, India.
    Rajkumar NN; Vijay RH
    J Assoc Physicians India; 2017 Jul; 65(7):14-17. PubMed ID: 28792162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.